Malignant metastatic insulinoma treated with streptozotocin.
A patient with metastatic insulinoma who suffered from severe hypoglycaemic attacks was treated with 7-5 g of streptozotocin (Upjohn). Shortly after the start of treatment, the hypoglycaemic attacks ceased; fasting blood glucose levels and serum immunoreactive insulin values returned to normal upon completion of the treatment. Two years after treatment, the patient is well and active and has not had any attacks. The oral glucose tolerance test and tolbutamide stimulation test now show serum immunoreactive insulin excretion patterns similar to those seen in diabetics.
D007516:Adenoma, Islet Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D001786:Blood Glucose; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology; D007328:Insulin / Q000097:blood; D008113:Liver Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D013311:Streptozocin / Q000627:therapeutic use*
D001786:Blood Glucose; D007328:Insulin; D013311:Streptozocin